Full Text View
Tabular View
No Study Results Posted
Related Studies
Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control
This study has been completed.
Study NCT00159302   Information provided by Imperial College London

First Received on September 8, 2005.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy Smokers
Healthy Non-Smokers
Patients With Mild Asthma
Patints With COPD (GOLD II)
Additional conditions recognized in this trial
Asthma
Pulmonary Disease, Chronic Obstructive
More general conditions related to this trial
Bronchial Diseases
Hypersensitivity
Hypersensitivity, Immediate
Immune System Diseases
Lung Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Respiratory Tract Diseases
Interventions listed in this trial
Induced Sputum
Exhaled Nitric Oxide
Nasal Nitric Oxide
Blood Tests
24hr Urine Samples
Exhaled Breath Condensate
Spirometry
Additional drug interventions recognized in this trial
Nitric Oxide
More general drug interventions related to this trial
Anti-Asthmatic Agents
Antioxidants
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Endothelium-Dependent Relaxing Factors
Free Radical Scavengers
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Respiratory System Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Imperial College London
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services